ReviewFrontiers in oncology2019

Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety.

Valentín García-Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.